Free shipping on orders over $75 · Shop the coastal collection

1-(2-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-2-oxoethyl)piperidine-4-carboxylic acid C17H12D8N4O3 Macrocyclic Dual-Locked “Turn-On” Drug for

SKU: 88950707809

4.8
USD540.00 USD584.00

Pay in 4 interest-free payments of $135.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 25 - Jul 30

Description

Macrocyclic Dual-Locked “Turn-On” Drug for Selective and Traceless Release in Cancer Cells

Dibromopyridazinedione

Chemically generated IgG2 bispecific antibodies through disulfide bridging

Chemical Production of Cytotoxic Bispecific Antibodies Using the Ugi Multicomponent Reaction

1-(2-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-2-oxoethyl)piperidine-4-carboxylic acid C17H12D8N4O3 Macrocyclic Dual-Locked “Turn-On” Drug for

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products

WordPress Appliance - Powered by TurnKey Linux